📰 Constantine Davides News
Constantine Davides News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Constantine Davides. Real-time updates on events, politics, business and more.
June 5, 2024
Analyst Constantine Davides from JMP Securities maintained a Buy rating on Agilon Health (AGL – Research Report) and keeping the price tar...
April 24, 2024
Operator: Good morning, and welcome to HealthStreams First Quarter 2024 Earnings Conference Call.
April 22, 2024
Evolent Health (NYSE:EVH) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bear...
April 9, 2024
It’s the most basic question investors face: What stocks to buy? The markets are tossing up a huge volume of data from millions upon millions of daily transactions, involving thousands of traders, dealers, and brokers, and thousands of public stocks. The data makes an imposing edifice – and is tailor made for data sorting tools like the Smart Score. The Smart Score is an AI-powered natural language algorithm, sophisticated enough to scan, collect, collate, and analyze all those rea...
February 23, 2024
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Evolent Health (NYSE:EVH) in the last thre...
February 23, 2024
Evolent Health, Inc. (NYSE: EVH) reported better-than-expected fourth-quarter results on Thursday.
January 8, 2024
In the latest quarter, 10 analysts provided ratings for Agilon Health (NYSE:AGL), showcasing a mix of bullish and bearish perspectives. In the tab...
July 12, 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Best biotech stocks represents a concept that, no matter what, the market cycle...
October 3, 2022
EQS-News: Healthcare Triangle, Inc. EF Hutton Reiterates Buy Rating On HCTI, Second Time in 2022 03.10.2022 / 15:28 CET/CEST The issuer is solely responsible for the content of this announcement. On September 28, 2022, Healthcare Triangle Inc (NASDAQ: HCTI) received a Buy rating with a price tar...
June 17, 2022
On Wednesday, the CFO of biotech firm HCW Biologics Inc (NASDAQ:HCWB), Rebecca Byam, disclosed in a US SEC filing that she purchased 66,452 shares